INCRELEX
INCRELEX
Approved
DIN Number
02509733
Drug Class
Human
Market Date
Mar 1, 2021
Company
HC
ipsen biopharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02509733
AIG Number0162642001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
H01AC03 MECASERMIN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:30.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
MECASERMINActive
Strength: 40 MG / 4 ML
Monograph: MECASERMIN